We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
-4.28%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$20.1B
AUM Growth
-$154M
(-0.76%)
Cap. Flow
+$988M
Cap. Flow
% of AUM
4.91%
Top 10 Holdings %
Top 10 Hldgs %
28.47%
Holding
777
New
61
Increased
377
Reduced
301
Closed
33
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Newmont
NEM
|
+$252M |
| 2 |
Nutrien
NTR
|
+$196M |
| 3 |
B
Barrick Mining
B
|
+$180M |
| 4 |
Franco-Nevada
FNV
|
+$165M |
| 5 |
GG
Goldcorp Inc
GG
|
+$146M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGU
Agrium
AGU
|
+$169M |
| 2 |
Union Pacific
UNP
|
+$63.1M |
| 3 |
POT
Potash Corp Of Saskatchewan
POT
|
+$43M |
| 4 |
CPE
Callon Petroleum Company
CPE
|
+$38.5M |
| 5 |
Louisiana-Pacific
LPX
|
+$31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 51.82% |
| 2 | Energy | 17.22% |
| 3 | Healthcare | 6.47% |
| 4 | Technology | 5.7% |
| 5 | Consumer Discretionary | 2.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
FS KKR Capital
FSK
$3.01B
| $11.3M | 0.06% |
389,815
-44,570
| -10% | -$1.33M |
|
227
Viatris
VTRS
$20.8B
| $11.1M | 0.06% |
270,628
-61,905
| -19% | -$2.64M |
|
|
GAU
228
Galiano Gold
GAU
$457M
| $10.9M | 0.05% |
10,938,375
-2,180,490
| -17% | -$1.82M |
|
229
AGNC Investment
AGNC
$12.7B
| $10.9M | 0.05% |
576,551
-23,535
| -4% | -$447K |
|
230
AGCO
AGCO
$8.41B
| $10.7M | 0.05% |
165,658
+12,809
| +8% | +$885K |
|
|
GRFS
231
Grifois
GRFS
$5.55B
| $10.6M | 0.05% |
499,074
-114,503
| -19% | -$2.61M |
|
232
AbbVie
ABBV
$465B
| $10.3M | 0.05% |
109,132
-33,650
| -24% | -$3.7M |
|
233
Teva Pharmaceuticals
TEVA
$40.4B
| $10.3M | 0.05% |
601,613
-255,485
| -30% | -$4.99M |
|
|
NEE.PRQ
234
DELISTED
NextEra Energy, Inc.
NEE.PRQ
| $9.9M | 0.05% |
135,768
+320
| +0.2% | +$22.1K |
|
|
KMI.PRA
235
DELISTED
Kinder Morgan, Inc.
KMI.PRA
| $9.65M | 0.05% |
310,328
+7,520
| +2% | +$267K |
|
|
IGEM
236
DELISTED
VanEck Vectors EM Investment Grade + BB Rated USD Sovereign Bond ETF
IGEM
| $9.22M | 0.05% |
385,000
| – | – |
|
|
LAC
237
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $9.16M | 0.05% |
+1,693,711
| New | +$11.1M |
|
238
Eaton
ETN
$141B
| $9.06M | 0.05% |
113,346
+4,629
| +4% | +$380K |
|
239
iShares Russell 1000 Growth ETF
IWF
$117B
| $8.85M | 0.04% |
260,020
+22,464
| +9% | +$787K |
|
|
EMAG
240
DELISTED
VanEck Vectors Emerging Markets Aggregate Bond ETF
EMAG
| $8.78M | 0.04% |
400,000
| – | – |
|
241
Neurocrine Biosciences
NBIX
$18.2B
| $8.64M | 0.04% |
104,240
-25,155
| -19% | -$2.12M |
|
242
Charles River Laboratories
CRL
$11.3B
| $8.58M | 0.04% |
80,385
-19,168
| -19% | -$2.07M |
|
|
CTLT
243
DELISTED
CATALENT, INC.
CTLT
| $8.56M | 0.04% |
208,394
+42,418
| +26% | +$1.8M |
|
|
DRD
244
DRDGold
DRD
$1.75B
| $8.54M | 0.04% |
3,129,564
+97,947
| +3% | +$294K |
|
245
Rithm Capital
RITM
$5.58B
| $8.49M | 0.04% |
516,263
+25,460
| +5% | +$433K |
|
246
Starwood Property Trust
STWD
$6.12B
| $8.26M | 0.04% |
394,390
-15,278
| -4% | -$316K |
|
|
FTSI
247
DELISTED
FTS International, Inc. Common Stock
FTSI
| $8.18M | 0.04% |
+22,250
| New | +$8.64M |
|
248
Alnylam Pharmaceuticals
ALNY
$38.3B
| $8.01M | 0.04% |
67,245
-19,454
| -22% | -$2.51M |
|
249
Golub Capital BDC
GBDC
$3.33B
| $7.88M | 0.04% |
449,952
+2,947
| +0.7% | +$52.2K |
|
250
Carlyle Secured Lending
CGBD
$708M
| $7.86M | 0.04% |
439,229
-12,842
| -3% | -$230K |
|
Similar funds
DAM
VanEck Associates's Q1 2018 Portfolio in Review
As of Q1 2018, VanEck Associates held 777 positions worth $20.1B, down 0.76% from $20.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
VanEck Associates deployed $988M of net new capital in Q1 2018, opening 61 new positions and adding to 377 existing holdings. Its largest new stake was Nutrien: 3,920,000 shares worth $185M.
By sector, the portfolio is most concentrated in Materials at 52% of assets, up from 50% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Louisiana-Pacific, an estimated $31M trimmed.
- VanEck Associates's largest Q1 2018 buy was Nutrien: 3,920,000 shares worth $185M.
- VanEck Associates added most to Newmont in Q1 2018, an estimated $252M increase.
- VanEck Associates's biggest Q1 2018 reduction was Louisiana-Pacific, cutting an estimated $31M.
- VanEck Associates fully exited Agrium in Q1 2018, selling an estimated $169M.
- VanEck Associates's ten largest holdings make up 28% of its $20.1B portfolio in Q1 2018.
- VanEck Associates opened 61 new positions and closed 33 in Q1 2018.
- VanEck Associates's portfolio value fell 0.76% quarter-over-quarter to $20.1B.
Based on VanEck Associates's 13F filing for Q1 2018, filed 11 May 2018.